Application of interpretable artificial neural networks to early monoclonal antibodies development.
Gentiluomo L, Roessner D, Augustijn D, Svilenov H, Kulakova A, Mahapatra S, Winter G, Streicher W, Rinnan Å, Peters GHJ, Harris P, Frieß W.
Gentiluomo L, et al. Among authors: peters ghj.
Eur J Pharm Biopharm. 2019 Aug;141:81-89. doi: 10.1016/j.ejpb.2019.05.017. Epub 2019 May 18.
Eur J Pharm Biopharm. 2019.
PMID: 31112768